GGrantIndex
Sort

50,496 grants matching lung cancer

Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer

$812,527
Steven M. Dubinett · University Of California Los Angeles · U01 · FY2015 · CA

Illinois Oncology Research Association Community Clinical Oncology Program

$812,293
Nguyet A. Le-Lindqwister · Oncology-Hematology Assoc-Central Ill · U10 · FY2012 · CA

Smoking Cessation and Smoking Relapse Prevention in Patients with Schizophrenia

$812,270
A Eden Evins · Massachusetts General Hospital · R01 · FY2007 · DA

Clinical CT Imaging for Screening and Subtyping of Pulmonary Hypertension in COPD

$812,189
Farbod Nicholas Rahaghi · Brigham And Women'S Hospital · R01 · FY2025 · HL

Improving access to multidisciplinary cancer care and patient outcomes by targeting physician networks

$812,123
Erika Moen · Dartmouth College · R37 · FY2025 · CA

DNA Repair Capacity Assays for Lung Disease Risk Assessment

$812,106
Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · U01 · FY2019 · CA

Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies

$811,718
David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Epigenetic Therapy for Thoracic Malignancies

$811,718
David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA

Genetic Epidemiology of Cancer

$811,554
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2012 · HG

The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression

$811,513
Nancy H. Colburn · Basic Sciences · Z01 · FY2007 · CA

Development of sEphB4-HSA as Novel Therapeutic in Cancer

$811,279
Valery G Krasnoperov · Vasgene Therapeutics, Inc · R44 · FY2013 · CA

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer

$811,268
Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2021 · CA

Core G: Clinical Cohort and Comorbidity Research

$811,224
Mari M Kitahata · University Of Washington · P30 · FY2020 · AI

Protein Structure, Stability, and Amyloid Formation

$811,099
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

The Role of Cripto in the Pathogenesis of Breast and Colon Cancer

$810,999
David Salomon · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

MOLECULAR APPROACHES TO DISCOVER MARINE NATURAL PRODUCT

$810,862
University Of California Santa Cruz · U19 · FY2003 · CA

BASED SYNTHETIC LETHALITY IN LUNG CANCER

$810,700
University Of Southern California · · FY2012 · Department of Defense

Enhancing ARIC Infrastructure to Yield a New Cancer Epidemiology Cohort

$810,571
Elizabeth A. Platz · Johns Hopkins University · U01 · FY2016 · CA

TARGETING LUNG-DERIVED PROTEINS AS A THERAPEUTIC STRATEGY AGAINST BREAST CANCER METASTASIS

$810,417
University Of Western Ontario · · FY2017 · Department of the Army

Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation

$810,359
Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

Vaccine and Drug Combination Therapy for Human Cancers

$810,351
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Vaccine and radiation for the therapy of human cancers

$810,351
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Small molecule enhancers of tumor immunity targeting the LPA5 GPCR

$810,231
Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2023 · CA

Primary Prevention to Reduce Cardiovascular Morbidity and Optimize Cancer Outcomes

$810,138
Aniket A Kawatkar · Kaiser Foundation Research Institute · R56 · FY2020 · HL

INHERITED AND SOMATIC ALTERATIONS OF THE TGF-B LIGAND AND RECEPTOR COMPLEX IN C..

$810,050
Christopher M Weghorst · Ohio State University · P50 · FY2011 · CA